NGAL - Bioporto

The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of NGAL in human urine and plasma on automated clinical chemistry analyzers. NGAL measurements are useful in the risk assesment of AKI.

News - Bioporto

Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury

BioPorto - Receives FDA clearance for NGAL test in the US - Inderes

The NGAL Test Reagent Kit - Bioporto

NGAL - Bioporto

BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration

Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19 - ScienceDirect

Bioporto afslutter patientoptag i Ngal-studie — MedWatch

News - Bioporto

BioPorto Diagnostics A/S: Contact Details and Business Profile

About BioPorto - Bioporto

May Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Predict Mortality in Patients with Hepatocellular Carcinoma (HCC)?

Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19 - ScienceDirect

Home - Bioporto